Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.01 USD | +4.24% | +2.80% | -14.98% |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
10/04 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Business Summary
Number of employees: 927
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 01/12/01 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 01/00/01 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 01/00/01 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/89/01 |
B. Parshall
BRD | Director/Board Member | 70 | 01/91/01 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 03/14/03 |
Brett Monia
FOU | Founder | 62 | 10/89/10 |
Joan Herman
BRD | Director/Board Member | 70 | 10/19/10 |
Joseph Klein
BRD | Director/Board Member | 62 | 13/05/13 |
B. Parshall
BRD | Director/Board Member | 70 | 01/91/01 |
Joseph Wender
BRD | Director/Board Member | 79 | 01/94/01 |
Director/Board Member | 71 | 01/02/01 | |
Michael Hayden
BRD | Director/Board Member | 72 | 24/18/24 |
Allene Diaz
BRD | Director/Board Member | 59 | 03/21/03 |
Michael Yang
BRD | Director/Board Member | 62 | 14/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,845,852 | 144,575,616 ( 99.13 %) | 0 | 99.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.98% | 6.02B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- IONS Stock
- Company Ionis Pharmaceuticals, Inc.